AJP - Cell Physiology, Vol 270, Issue 5 C1544-C1555, Copyright © 1996 by American Physiological Society

ARTICLES

Delta F508-CFTR channels: kinetics, activation by forskolin, and potentiation by xanthines

C. M. Haws, I. B. Nepomuceno, M. E. Krouse, H. Wakelee, T. Law, Y. Xia, H. Nguyen and J. J. Wine
Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.

Trafficking, activation, and kinetics of delta F508-cystic fibrosis transmembrane conductance regulator (CFTR) and CFTR were compared in stably transduced C127I mouse mammary epithelial cells. Western blots detected a small amount of fully glycosylated delta F508-CFTR Efflux of 125I was stimulated by forskolin with the same mean effective concentration (EC50; approximately 0.5 microM) for CFTR and delta F508-CFTR cells, but the maximum response was reduced more than fivefold and its latency increased approximately threefold in delta F508-CFTR cells. In delta F508-CFTR cells, 3-isobutyl-1-methylxanthine (IBMX; EC50 = 1.45 microM) and 8-cyclopentyl-1,3-dipropylxanthine (CPX; EC50 = 58 microM) increased the peak forskolin-stimulated efflux rate approximately 2.5-fold and decreased the time to peak. A sevenfold increase in intracellular adenosine 3',5'-cyclic monophosphate (cAMP) levels accompanied potentiation of forskolin-induced 125I efflux by IBMX but not by CPX. Elevation of intracellular cAMP increased linear voltage-independent whole cell currents 30-fold in CFTR and 4-fold in delta F508-CFTR cells; the response rate in delta F508-CFTR cells was much slower. Single-channel currents were detected in 57 of 68 cell-attached patches from forskolin-prestimulated CFTR cells vs. 6 of 35 patches in delta F508-CFTR cells. Mean number of active channels per patch was 4.1 for CFTR [open probability (Po) = 0.34] and 0.2 for delta F508-CFTR (Po = 0.11). The lower Po of delta F508-CFTR resulted from an approximately threefold longer mean interburst interval. We estimate that forskolin-stimulated chloride conductance of delta F508-CFTR C127I cells is < 5% of CFTR cells. CPX is approximately 25-fold more potent than IBMX in potentiating delta F508-CFTR and may operate by a mechanism other than elevation of cAMP.

This article has been cited by other articles:

				L. L. Clarke, L. R. Gawenis, T.-C. Hwang, N. M. Walker, D. B. Gruis, and E. M. Price A domain mimic increases {Delta}F508 CFTR trafficking and restores cAMP-stimulated anion secretion in cystic fibrosis epithelia Am J Physiol Cell Physiol, July 1, 2004; 287(1): C192 - C199. [Abstract] [Full Text] [PDF]

				E. Caci, C. Folli, O. Zegarra-Moran, T. Ma, M. F. Springsteel, R. E. Sammelson, M. H. Nantz, M. J. Kurth, A. S. Verkman, and L. J. V. Galietta CFTR activation in human bronchial epithelial cells by novel benzoflavone and benzimidazolone compounds Am J Physiol Lung Cell Mol Physiol, July 1, 2003; 285(1): L180 - L188. [Abstract] [Full Text] [PDF]

				H. Fischer, N. Fukuda, P. Barbry, B. Illek, C. Sartori, and M. A. Matthay Partial restoration of defective chloride conductance in {Delta}F508 CF mice by trimethylamine oxide Am J Physiol Lung Cell Mol Physiol, July 1, 2001; 281(1): L52 - L57. [Abstract] [Full Text] [PDF]

				L. Al-Nakkash, S. Hu, M. Li, and T.-C. Hwang A Common Mechanism for Cystic Fibrosis Transmembrane Conductance Regulator Protein Activation by Genistein and Benzimidazolone Analogs J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 464 - 472. [Abstract] [Full Text]

				G. D. Heda, M. Tanwani, and C. R. Marino The {Delta}F508 mutation shortens the biochemical half-life of plasma membrane CFTR in polarized epithelial cells Am J Physiol Cell Physiol, January 1, 2001; 280(1): C166 - C174. [Abstract] [Full Text] [PDF]

				L. Bulteau, R. Derand, Y. Mettey, T. Metaye, M. R. Morris, C. M. McNeilly, C. Folli, L. J. V. Galietta, O. Zegarra-Moran, M. M. C. Pereira, et al. Properties of CFTR activated by the xanthine derivative X-33 in human airway Calu-3 cells Am J Physiol Cell Physiol, December 1, 2000; 279(6): C1925 - C1937. [Abstract] [Full Text] [PDF]

				B. D. SCHULTZ, A. K. SINGH, D. C. DEVOR, and R. J. BRIDGES Pharmacology of CFTR Chloride Channel Activity Physiol Rev, January 1, 1999; 79(1): 109 - 144. [Abstract] [Full Text] [PDF]

				B. Illek, H. Fischer, and T. E. Machen II. Regulation of CFTR by small molecules including HCO-3 Am J Physiol Gastrointest Liver Physiol, December 1, 1998; 275(6): G1221 - G1226. [Abstract] [Full Text] [PDF]

				Z. He, S. Raman, Y. Guo, and W. W. Reenstra Cystic fibrosis transmembrane conductance regulator activation by cAMP-independent mechanisms Am J Physiol Cell Physiol, October 1, 1998; 275(4): C958 - C966. [Abstract] [Full Text] [PDF]

				T. J. Kelley, C. U. Cotton, and M. L. Drumm Regulation of amiloride-sensitive sodium absorption in murine airway epithelium by C-type natriuretic peptide Am J Physiol Lung Cell Mol Physiol, June 1, 1998; 274(6): L990 - L996. [Abstract] [Full Text] [PDF]

				T. J. Kelley, K. Thomas, L. J. H. Milgram, and M. L. Drumm In vivo activation of the cystic fibrosis transmembrane conductance regulator mutant Delta F508 in murine nasal epithelium PNAS, March 18, 1997; 94(6): 2604 - 2608. [Abstract] [Full Text] [PDF]

				R. Mohammad-Panah, K. Gyomorey, J. Rommens, M. Choudhury, C. Li, Y. Wang, and C. E. Bear ClC-2 Contributes to Native Chloride Secretion by a Human Intestinal Cell Line, Caco-2 J. Biol. Chem., March 9, 2001; 276(11): 8306 - 8313. [Abstract] [Full Text] [PDF]

				J. V. Wu, N. S. Joo, M. E. Krouse, and J. J. Wine Cystic Fibrosis Transmembrane Conductance Regulator Gating Requires Cytosolic Electrolytes J. Biol. Chem., February 23, 2001; 276(9): 6473 - 6478. [Abstract] [Full Text] [PDF]